{"gene":"ZC3H18","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":2018,"finding":"ZC3H18 is a multi-domain protein that physically associates with the cap-binding complex (CBC) via a dedicated CBC-interacting domain, and separately associates with the nuclear exosome targeting (NEXT) complex, positioning it at the interface of RNA production and destruction. It also associates with core histone proteins through a phosphorylation-dependent region. Mutagenesis of each domain demonstrated that the CBC-interacting domain is required for ZC3H18's impact on transcription of a subset of protein-coding genes, with some genes additionally dependent on the NEXT- and/or histone-interacting domains.","method":"Interaction screening (co-immunoprecipitation/affinity purification), mutagenesis of ZC3H18 domains, genome-wide transcriptional analyses, identification of a phosphorylation-dependent isoform","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal interaction screening combined with domain mutagenesis and genome-wide functional readouts in a single focused study","pmids":["29298432"],"is_preprint":false},{"year":2014,"finding":"ZC3H18 directly binds the SEP1 sub-element of the hepatitis B virus PRE RNA, physically interacts with the TREX mRNA export complex, and is required for stable association of TREX with SEP1-containing mRNA, thereby facilitating nuclear export of intronless and polyA mRNAs. ZC3H18 is also required for efficient nuclear export of polyA RNAs in general.","method":"Affinity purification of SEP1-RNP followed by mass spectrometry, RNA binding assays, co-immunoprecipitation of ZC3H18 with TREX components, siRNA knockdown with nuclear export readouts","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct RNA binding, reciprocal co-IP with TREX, and loss-of-function export phenotype established in a single study with multiple orthogonal methods","pmids":["24782531"],"is_preprint":false},{"year":2019,"finding":"ZC3H18 functions as a DNA-binding protein that binds an E2F site in the BRCA1 promoter and facilitates recruitment of E2F4 to an adjacent E2F site, thereby transcriptionally activating BRCA1. ZC3H18 depletion induces BRCA1 promoter methylation, reduces BRCA1 expression, disrupts homologous recombination (HR), and sensitizes ovarian cancer cells to DNA crosslinkers and PARP inhibitors.","method":"Chromatin immunoprecipitation (ChIP) demonstrating ZC3H18 and E2F4 binding to the BRCA1 promoter, siRNA knockdown with BRCA1 expression readout, methylation-specific PCR for promoter methylation, HR assays, drug sensitivity assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-based DNA binding, co-IP of ZC3H18 with E2F4, loss-of-function with multiple orthogonal functional readouts (HR assay, promoter methylation, drug sensitivity) in a single rigorous study","pmids":["31604914"],"is_preprint":false},{"year":2023,"finding":"ZC3H18 promotes NEXT/exosome-mediated decay of capped, short unadenylated transcripts via its association with ARS2 and the NEXT complex. Concurrently, ZC3H18 antagonizes the PAXT pathway: an acidic-rich short linear motif in ZC3H18 competes with an analogous motif in the core PAXT component ZFC3H1 for a common binding epitope on ARS2, thereby suppressing PAXT activity. This dual agonist/antagonist role enables co-activation of NEXT and PAXT at loci producing abundant short exosome substrates.","method":"Mutational analysis of ZFC3H1 (PAXT core component), co-immunoprecipitation mapping ZC3H18 and ZFC3H1 competition for ARS2, RNA decay assays distinguishing NEXT and PAXT substrates","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — mutational dissection of competing short linear motifs combined with co-IP mapping and RNA decay functional readouts in a single focused study","pmids":["37889751"],"is_preprint":false},{"year":2025,"finding":"Truncating mutations in ZC3H18 (Z18trunc) found recurrently in cancer act as dominant negatives: Z18trunc directly bound and stabilized endogenous retroviral (ERV) RNA rather than targeting it for nuclear RNA surveillance/decay, leading to ERV RNA accumulation. In zebrafish, Z18trunc expedited melanoma onset and ERV RNA expression was sufficient to expedite oncogenesis, establishing that ZC3H18 normally suppresses ERV transcripts through nuclear RNA surveillance.","method":"Zebrafish melanoma model expressing Z18trunc, engineered human melanoma cell lines expressing Z18trunc, RNA binding assays demonstrating direct binding of Z18trunc to ERV RNA, Cancer Cell Line Encyclopedia Z18 mutant data, genetic loss-of-function comparisons","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vivo zebrafish model and direct RNA binding assay with engineered human cells, but single preprint lab study not yet peer-reviewed","pmids":["39868094"],"is_preprint":true},{"year":2026,"finding":"USP39 directly interacts with ZC3H18 and deubiquitinates it, thereby enhancing ZC3H18 protein stability. Stabilized ZC3H18 in turn suppresses methylation of the BRCA1 promoter, promoting BRCA1 expression and mitochondrial biogenesis, contributing to carboplatin resistance in ovarian cancer.","method":"Co-immunoprecipitation validating USP39–ZC3H18 interaction, western blotting for ZC3H18 stability upon USP39 knockdown/overexpression, methylation-specific PCR for BRCA1 promoter methylation, Seahorse XFp for mitochondrial function, rescue experiments with ZC3H18 overexpression after USP39 knockdown","journal":"3 Biotech","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — co-IP validated interaction with deubiquitination functional readout and rescue epistasis, but single lab study with no independent replication","pmids":["42205906"],"is_preprint":false}],"current_model":"ZC3H18 is a multi-functional zinc finger protein that bridges nuclear RNA production and destruction: it binds the cap-binding complex (CBC) and directly recruits the TREX mRNA export machinery to capped transcripts to facilitate nuclear export, while simultaneously associating with the NEXT complex via ARS2 to target short unadenylated capped RNAs for exosome-mediated decay, and competitively antagonizes the parallel PAXT decay pathway through a shared ARS2 binding motif; additionally, ZC3H18 binds the BRCA1 promoter as a DNA-binding protein to recruit E2F4 and activate BRCA1 transcription (a function stabilized by USP39-mediated deubiquitination), and its nuclear surveillance function normally suppresses endogenous retroviral RNA, with truncating mutations acting as dominant negatives to stabilize ERV transcripts and promote oncogenesis."},"narrative":{"mechanistic_narrative":"ZC3H18 is a multi-domain nuclear zinc finger protein that operates at the interface of RNA production and destruction, coordinating both nuclear export of capped transcripts and their exosome-mediated decay [PMID:29298432]. Through a dedicated cap-binding complex (CBC)-interacting domain it associates with the CBC, while a separate region engages the nuclear exosome targeting (NEXT) complex and a phosphorylation-dependent region binds core histones; these domains are differentially required for ZC3H18's effects on transcription of subsets of protein-coding genes [PMID:29298432]. On the export arm, ZC3H18 directly binds RNA—including the SEP1 sub-element of the hepatitis B virus PRE—and recruits the TREX export machinery to capped transcripts, supporting efficient nuclear export of intronless, polyA, and general polyA RNAs [PMID:24782531]. On the decay arm, ZC3H18 promotes NEXT/exosome turnover of short, capped, unadenylated transcripts via ARS2, and through an acidic-rich short linear motif competes with the PAXT component ZFC3H1 for a shared ARS2 epitope, antagonizing PAXT and thereby balancing the two decay pathways [PMID:37889751]. Independently of its RNA roles, ZC3H18 acts as a DNA-binding transcriptional activator at the BRCA1 promoter, binding an E2F site and recruiting E2F4 to drive BRCA1 expression; its depletion induces BRCA1 promoter methylation, impairs homologous recombination, and sensitizes ovarian cancer cells to crosslinkers and PARP inhibitors [PMID:31604914]. ZC3H18 protein stability is enhanced by USP39-mediated deubiquitination, which sustains BRCA1 expression and contributes to carboplatin resistance [PMID:42205906], and its nuclear surveillance function normally suppresses endogenous retroviral RNA, with recurrent truncating mutations acting as dominant negatives that stabilize ERV transcripts and promote oncogenesis [PMID:39868094].","teleology":[{"year":2014,"claim":"Established ZC3H18 as a direct RNA-binding adaptor that recruits the TREX export machinery to capped mRNAs, defining its role in nuclear RNA export.","evidence":"Affinity purification of SEP1-RNP with mass spectrometry, RNA binding assays, co-IP with TREX components, and siRNA knockdown with nuclear export readouts","pmids":["24782531"],"confidence":"High","gaps":["Did not resolve which TREX subunit ZC3H18 contacts directly","Generality of export defect across endogenous transcript classes not fully mapped"]},{"year":2018,"claim":"Resolved the modular architecture of ZC3H18, showing distinct domains that bridge the CBC, the NEXT exosome-targeting complex, and histones, placing it at the production/destruction interface.","evidence":"Reciprocal co-IP/affinity purification interaction screening, domain mutagenesis, genome-wide transcriptional analyses in human cells","pmids":["29298432"],"confidence":"High","gaps":["Mechanism by which histone association influences transcription not defined","How export versus decay outcomes are selected at individual loci unclear"]},{"year":2019,"claim":"Revealed an unexpected chromatin-associated function: ZC3H18 binds the BRCA1 promoter as a DNA-binding protein and recruits E2F4 to activate BRCA1, linking it to homologous recombination competence.","evidence":"ChIP for ZC3H18 and E2F4 promoter occupancy, siRNA knockdown with BRCA1 readout, methylation-specific PCR, HR assays, and drug sensitivity assays in ovarian cancer cells","pmids":["31604914"],"confidence":"High","gaps":["DNA sequence specificity and direct versus indirect promoter binding not structurally defined","Relationship between RNA-handling and DNA-binding functions unresolved"]},{"year":2023,"claim":"Defined the molecular basis of ZC3H18's dual control of nuclear decay, showing it both activates NEXT and competitively antagonizes PAXT through a shared ARS2 binding motif.","evidence":"Mutational analysis of ZFC3H1, co-IP mapping of ZC3H18/ZFC3H1 competition for ARS2, and RNA decay assays distinguishing NEXT and PAXT substrates","pmids":["37889751"],"confidence":"High","gaps":["Structural detail of the competing short linear motifs on ARS2 not determined","Physiological loci where this balance matters not comprehensively cataloged"]},{"year":2025,"claim":"Connected ZC3H18 nuclear surveillance to tumor suppression, showing recurrent truncating mutants act as dominant negatives that stabilize rather than degrade ERV RNA and accelerate melanoma.","evidence":"Zebrafish melanoma model and engineered human melanoma cells expressing Z18trunc, RNA binding assays, and CCLE mutant data (preprint)","pmids":["39868094"],"confidence":"Medium","gaps":["Single preprint lab study not yet peer-reviewed","Mechanism by which truncation converts decay targeting into stabilization undefined"]},{"year":2026,"claim":"Identified a post-translational regulator of ZC3H18, showing USP39-mediated deubiquitination stabilizes the protein to sustain BRCA1 expression and drive chemoresistance.","evidence":"Co-IP of USP39–ZC3H18, western blotting for stability upon USP39 manipulation, methylation-specific PCR, Seahorse mitochondrial assays, and ZC3H18 rescue experiments","pmids":["42205906"],"confidence":"Medium","gaps":["Single lab study without independent replication","Ubiquitin ligase opposing USP39 not identified","Direct link between ZC3H18 stability and mitochondrial biogenesis not mechanistically dissected"]},{"year":null,"claim":"How ZC3H18 partitions a given capped transcript between TREX-mediated export and NEXT/exosome decay, and how its chromatin/DNA-binding role is coordinated with its RNA-handling functions, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model integrating CBC, NEXT, TREX, and ARS2 interactions","Signals governing export-versus-decay choice unknown","Mechanistic link between DNA-binding transcriptional role and RNA surveillance role unestablished"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[1,4]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1,3]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,2]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,1,3]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[2]}],"complexes":[],"partners":["ARS2","ZFC3H1","E2F4","USP39"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q86VM9","full_name":"Zinc finger CCCH domain-containing protein 18","aliases":["Nuclear protein NHN1"],"length_aa":953,"mass_kda":106.4,"function":"","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q86VM9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/ZC3H18","classification":"Common Essential","n_dependent_lines":932,"n_total_lines":1208,"dependency_fraction":0.7715231788079471},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"PRPF4B","stoichiometry":4.0},{"gene":"CPSF6","stoichiometry":0.2},{"gene":"DDX21","stoichiometry":0.2},{"gene":"RBM39","stoichiometry":0.2},{"gene":"RBM42","stoichiometry":0.2},{"gene":"RBM6","stoichiometry":0.2},{"gene":"RNF40","stoichiometry":0.2},{"gene":"SF3A1","stoichiometry":0.2},{"gene":"SF3A2","stoichiometry":0.2},{"gene":"SF3B1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ZC3H18","total_profiled":1310},"omim":[{"mim_id":"620956","title":"ZINC FINGER C3H1 DOMAIN-CONTAINING PROTEIN; ZFC3H1","url":"https://www.omim.org/entry/620956"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nuclear speckles","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ZC3H18"},"hgnc":{"alias_symbol":["NHN1"],"prev_symbol":[]},"alphafold":{"accession":"Q86VM9","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86VM9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q86VM9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q86VM9-F1-predicted_aligned_error_v6.png","plddt_mean":51.78},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ZC3H18","jax_strain_url":"https://www.jax.org/strain/search?query=ZC3H18"},"sequence":{"accession":"Q86VM9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q86VM9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q86VM9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86VM9"}},"corpus_meta":[{"pmid":"29298432","id":"PMC_29298432","title":"Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29298432","citation_count":48,"is_preprint":false},{"pmid":"24782531","id":"PMC_24782531","title":"A Sub-Element in PRE enhances nuclear export of intronless mRNAs by recruiting the TREX complex via ZC3H18.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24782531","citation_count":48,"is_preprint":false},{"pmid":"31604914","id":"PMC_31604914","title":"ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31604914","citation_count":21,"is_preprint":false},{"pmid":"21354218","id":"PMC_21354218","title":"The Trypanosoma brucei zinc finger protein ZC3H18 is involved in differentiation.","date":"2011","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/21354218","citation_count":20,"is_preprint":false},{"pmid":"37889751","id":"PMC_37889751","title":"Dual agonistic and antagonistic roles of ZC3H18 provide for co-activation of distinct nuclear RNA decay pathways.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37889751","citation_count":14,"is_preprint":false},{"pmid":"40354417","id":"PMC_40354417","title":"STAT3, MYC, and EBNA1 cooperate through a ZC3H18 transcriptional network to regulate survival and proliferation of EBV-positive lymphomas.","date":"2025","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/40354417","citation_count":4,"is_preprint":false},{"pmid":"39868094","id":"PMC_39868094","title":"Recurrent oncogenic ZC3H18 mutations stabilize endogenous retroviral RNA.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39868094","citation_count":2,"is_preprint":false},{"pmid":"40070828","id":"PMC_40070828","title":"Zinc finger protein ZC3H18 is abnormally expressed in esophageal cancer tissues and facilitates the proliferation of esophageal cancer cells.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40070828","citation_count":0,"is_preprint":false},{"pmid":"40995431","id":"PMC_40995431","title":"ZC3H18 regulates alternative splicing and related genes in cervical cancer.","date":"2025","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40995431","citation_count":0,"is_preprint":false},{"pmid":"42205906","id":"PMC_42205906","title":"USP39 reduces BRCA1 methylation to promote mitochondrial biogenesis and lower drug sensitivity in ovarian cancer through deubiquitinating ZC3H18.","date":"2026","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/42205906","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6827,"output_tokens":2044,"usd":0.02557,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9059,"output_tokens":2886,"usd":0.058722,"stage2_stop_reason":"end_turn"},"total_usd":0.084292,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"ZC3H18 is a multi-domain protein that physically associates with the cap-binding complex (CBC) via a dedicated CBC-interacting domain, and separately associates with the nuclear exosome targeting (NEXT) complex, positioning it at the interface of RNA production and destruction. It also associates with core histone proteins through a phosphorylation-dependent region. Mutagenesis of each domain demonstrated that the CBC-interacting domain is required for ZC3H18's impact on transcription of a subset of protein-coding genes, with some genes additionally dependent on the NEXT- and/or histone-interacting domains.\",\n      \"method\": \"Interaction screening (co-immunoprecipitation/affinity purification), mutagenesis of ZC3H18 domains, genome-wide transcriptional analyses, identification of a phosphorylation-dependent isoform\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal interaction screening combined with domain mutagenesis and genome-wide functional readouts in a single focused study\",\n      \"pmids\": [\"29298432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ZC3H18 directly binds the SEP1 sub-element of the hepatitis B virus PRE RNA, physically interacts with the TREX mRNA export complex, and is required for stable association of TREX with SEP1-containing mRNA, thereby facilitating nuclear export of intronless and polyA mRNAs. ZC3H18 is also required for efficient nuclear export of polyA RNAs in general.\",\n      \"method\": \"Affinity purification of SEP1-RNP followed by mass spectrometry, RNA binding assays, co-immunoprecipitation of ZC3H18 with TREX components, siRNA knockdown with nuclear export readouts\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct RNA binding, reciprocal co-IP with TREX, and loss-of-function export phenotype established in a single study with multiple orthogonal methods\",\n      \"pmids\": [\"24782531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ZC3H18 functions as a DNA-binding protein that binds an E2F site in the BRCA1 promoter and facilitates recruitment of E2F4 to an adjacent E2F site, thereby transcriptionally activating BRCA1. ZC3H18 depletion induces BRCA1 promoter methylation, reduces BRCA1 expression, disrupts homologous recombination (HR), and sensitizes ovarian cancer cells to DNA crosslinkers and PARP inhibitors.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) demonstrating ZC3H18 and E2F4 binding to the BRCA1 promoter, siRNA knockdown with BRCA1 expression readout, methylation-specific PCR for promoter methylation, HR assays, drug sensitivity assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-based DNA binding, co-IP of ZC3H18 with E2F4, loss-of-function with multiple orthogonal functional readouts (HR assay, promoter methylation, drug sensitivity) in a single rigorous study\",\n      \"pmids\": [\"31604914\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ZC3H18 promotes NEXT/exosome-mediated decay of capped, short unadenylated transcripts via its association with ARS2 and the NEXT complex. Concurrently, ZC3H18 antagonizes the PAXT pathway: an acidic-rich short linear motif in ZC3H18 competes with an analogous motif in the core PAXT component ZFC3H1 for a common binding epitope on ARS2, thereby suppressing PAXT activity. This dual agonist/antagonist role enables co-activation of NEXT and PAXT at loci producing abundant short exosome substrates.\",\n      \"method\": \"Mutational analysis of ZFC3H1 (PAXT core component), co-immunoprecipitation mapping ZC3H18 and ZFC3H1 competition for ARS2, RNA decay assays distinguishing NEXT and PAXT substrates\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutational dissection of competing short linear motifs combined with co-IP mapping and RNA decay functional readouts in a single focused study\",\n      \"pmids\": [\"37889751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Truncating mutations in ZC3H18 (Z18trunc) found recurrently in cancer act as dominant negatives: Z18trunc directly bound and stabilized endogenous retroviral (ERV) RNA rather than targeting it for nuclear RNA surveillance/decay, leading to ERV RNA accumulation. In zebrafish, Z18trunc expedited melanoma onset and ERV RNA expression was sufficient to expedite oncogenesis, establishing that ZC3H18 normally suppresses ERV transcripts through nuclear RNA surveillance.\",\n      \"method\": \"Zebrafish melanoma model expressing Z18trunc, engineered human melanoma cell lines expressing Z18trunc, RNA binding assays demonstrating direct binding of Z18trunc to ERV RNA, Cancer Cell Line Encyclopedia Z18 mutant data, genetic loss-of-function comparisons\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vivo zebrafish model and direct RNA binding assay with engineered human cells, but single preprint lab study not yet peer-reviewed\",\n      \"pmids\": [\"39868094\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"USP39 directly interacts with ZC3H18 and deubiquitinates it, thereby enhancing ZC3H18 protein stability. Stabilized ZC3H18 in turn suppresses methylation of the BRCA1 promoter, promoting BRCA1 expression and mitochondrial biogenesis, contributing to carboplatin resistance in ovarian cancer.\",\n      \"method\": \"Co-immunoprecipitation validating USP39–ZC3H18 interaction, western blotting for ZC3H18 stability upon USP39 knockdown/overexpression, methylation-specific PCR for BRCA1 promoter methylation, Seahorse XFp for mitochondrial function, rescue experiments with ZC3H18 overexpression after USP39 knockdown\",\n      \"journal\": \"3 Biotech\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — co-IP validated interaction with deubiquitination functional readout and rescue epistasis, but single lab study with no independent replication\",\n      \"pmids\": [\"42205906\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ZC3H18 is a multi-functional zinc finger protein that bridges nuclear RNA production and destruction: it binds the cap-binding complex (CBC) and directly recruits the TREX mRNA export machinery to capped transcripts to facilitate nuclear export, while simultaneously associating with the NEXT complex via ARS2 to target short unadenylated capped RNAs for exosome-mediated decay, and competitively antagonizes the parallel PAXT decay pathway through a shared ARS2 binding motif; additionally, ZC3H18 binds the BRCA1 promoter as a DNA-binding protein to recruit E2F4 and activate BRCA1 transcription (a function stabilized by USP39-mediated deubiquitination), and its nuclear surveillance function normally suppresses endogenous retroviral RNA, with truncating mutations acting as dominant negatives to stabilize ERV transcripts and promote oncogenesis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ZC3H18 is a multi-domain nuclear zinc finger protein that operates at the interface of RNA production and destruction, coordinating both nuclear export of capped transcripts and their exosome-mediated decay [#0]. Through a dedicated cap-binding complex (CBC)-interacting domain it associates with the CBC, while a separate region engages the nuclear exosome targeting (NEXT) complex and a phosphorylation-dependent region binds core histones; these domains are differentially required for ZC3H18's effects on transcription of subsets of protein-coding genes [#0]. On the export arm, ZC3H18 directly binds RNA—including the SEP1 sub-element of the hepatitis B virus PRE—and recruits the TREX export machinery to capped transcripts, supporting efficient nuclear export of intronless, polyA, and general polyA RNAs [#1]. On the decay arm, ZC3H18 promotes NEXT/exosome turnover of short, capped, unadenylated transcripts via ARS2, and through an acidic-rich short linear motif competes with the PAXT component ZFC3H1 for a shared ARS2 epitope, antagonizing PAXT and thereby balancing the two decay pathways [#3]. Independently of its RNA roles, ZC3H18 acts as a DNA-binding transcriptional activator at the BRCA1 promoter, binding an E2F site and recruiting E2F4 to drive BRCA1 expression; its depletion induces BRCA1 promoter methylation, impairs homologous recombination, and sensitizes ovarian cancer cells to crosslinkers and PARP inhibitors [#2]. ZC3H18 protein stability is enhanced by USP39-mediated deubiquitination, which sustains BRCA1 expression and contributes to carboplatin resistance [#5], and its nuclear surveillance function normally suppresses endogenous retroviral RNA, with recurrent truncating mutations acting as dominant negatives that stabilize ERV transcripts and promote oncogenesis [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 2014,\n      \"claim\": \"Established ZC3H18 as a direct RNA-binding adaptor that recruits the TREX export machinery to capped mRNAs, defining its role in nuclear RNA export.\",\n      \"evidence\": \"Affinity purification of SEP1-RNP with mass spectrometry, RNA binding assays, co-IP with TREX components, and siRNA knockdown with nuclear export readouts\",\n      \"pmids\": [\"24782531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Did not resolve which TREX subunit ZC3H18 contacts directly\",\n        \"Generality of export defect across endogenous transcript classes not fully mapped\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved the modular architecture of ZC3H18, showing distinct domains that bridge the CBC, the NEXT exosome-targeting complex, and histones, placing it at the production/destruction interface.\",\n      \"evidence\": \"Reciprocal co-IP/affinity purification interaction screening, domain mutagenesis, genome-wide transcriptional analyses in human cells\",\n      \"pmids\": [\"29298432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which histone association influences transcription not defined\",\n        \"How export versus decay outcomes are selected at individual loci unclear\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Revealed an unexpected chromatin-associated function: ZC3H18 binds the BRCA1 promoter as a DNA-binding protein and recruits E2F4 to activate BRCA1, linking it to homologous recombination competence.\",\n      \"evidence\": \"ChIP for ZC3H18 and E2F4 promoter occupancy, siRNA knockdown with BRCA1 readout, methylation-specific PCR, HR assays, and drug sensitivity assays in ovarian cancer cells\",\n      \"pmids\": [\"31604914\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"DNA sequence specificity and direct versus indirect promoter binding not structurally defined\",\n        \"Relationship between RNA-handling and DNA-binding functions unresolved\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined the molecular basis of ZC3H18's dual control of nuclear decay, showing it both activates NEXT and competitively antagonizes PAXT through a shared ARS2 binding motif.\",\n      \"evidence\": \"Mutational analysis of ZFC3H1, co-IP mapping of ZC3H18/ZFC3H1 competition for ARS2, and RNA decay assays distinguishing NEXT and PAXT substrates\",\n      \"pmids\": [\"37889751\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural detail of the competing short linear motifs on ARS2 not determined\",\n        \"Physiological loci where this balance matters not comprehensively cataloged\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected ZC3H18 nuclear surveillance to tumor suppression, showing recurrent truncating mutants act as dominant negatives that stabilize rather than degrade ERV RNA and accelerate melanoma.\",\n      \"evidence\": \"Zebrafish melanoma model and engineered human melanoma cells expressing Z18trunc, RNA binding assays, and CCLE mutant data (preprint)\",\n      \"pmids\": [\"39868094\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single preprint lab study not yet peer-reviewed\",\n        \"Mechanism by which truncation converts decay targeting into stabilization undefined\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identified a post-translational regulator of ZC3H18, showing USP39-mediated deubiquitination stabilizes the protein to sustain BRCA1 expression and drive chemoresistance.\",\n      \"evidence\": \"Co-IP of USP39–ZC3H18, western blotting for stability upon USP39 manipulation, methylation-specific PCR, Seahorse mitochondrial assays, and ZC3H18 rescue experiments\",\n      \"pmids\": [\"42205906\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single lab study without independent replication\",\n        \"Ubiquitin ligase opposing USP39 not identified\",\n        \"Direct link between ZC3H18 stability and mitochondrial biogenesis not mechanistically dissected\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ZC3H18 partitions a given capped transcript between TREX-mediated export and NEXT/exosome decay, and how its chromatin/DNA-binding role is coordinated with its RNA-handling functions, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural model integrating CBC, NEXT, TREX, and ARS2 interactions\",\n        \"Signals governing export-versus-decay choice unknown\",\n        \"Mechanistic link between DNA-binding transcriptional role and RNA surveillance role unestablished\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ARS2\", \"ZFC3H1\", \"E2F4\", \"USP39\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":6,"faith_total":6,"faith_pct":100.0}}